Ling Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ling Yao has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Chunli Li
Institute of Life Sciences Chongqing Medical University 1 Yixueyuan Road Yuzhong District Chongqing 400016 P. R. China
1 shared publicationChunlin Yuan
Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases College of Traditional Chinese Medicine, 1 Yixueyuan Road Chongqing Medical University Yuzhong District Chongqing 400016 P. R. China
1 shared publication- Da-Zhi Ke
The Second Affiliated Hospital, Chongqing Medical University, China
1 shared publication - Dan Zhang
College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing 400016, China
1 shared publication Dazhi Ke
The Second Affiliated Hospital of Chongqing Medical University 74 Linjiang Road, Yuzhong District Chongqing 400010 P. R. China
1 shared publicationJianwei Wang
Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases College of Traditional Chinese Medicine, 1 Yixueyuan Road Chongqing Medical University Yuzhong District Chongqing 400016 P. R. China
1 shared publication
Latest Publications
- 8 May 2023
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 67 (12) , e2200533
Oleanolic Acid Inhibits SCD1 Gene Expression to Ameliorate Fructose‐Induced Hepatosteatosis through SREBP1c‐Dependent and ‐Independent Mechanisms
Scope: The mechanisms of oleanolic acid (OA) regulating hepatic sterol regulatory element‐binding protein (SREBP) 1c/stearoyl‐CoA desaturase (SCD) 1 pathway to ameliorate fructose‐induced hepatosteatosis are investigated.Methods and results: Rats treated with 10% w/v fructose solution are co‐administered by OA for 5 weeks, and then sacrifice after fasting for 14 h. OA reverses the fructose‐induced increase in hepatic triglyceride (TG) content and downregulates Scd1 mRNA expression. However, two upstream transcription factors, ChREBP and SREBP1c, remain at normal levels with or without fructose and/or OA. In vivo and in vitro studies using SREBP1c−/− mice and HepG2 cell models show that OA also inhibits SCD1 gene overexpression and high hepatic TG levels induced by fructose. On the other hand, in SCD1−/− mice, when the fructose diet is supplemented with high levels of oleic acid (OLA) to compensate for the deficiency of SCD1, OA inhibits hepatic SREBP1c and lipogenic gene expression and reduces hepatic OLA (C18:1) production to improve fructose and/or OLA induced liver lipid deposition. Furthermore, OA promotes PPARα and AMPK to enhance fatty acid oxidation in fructose + OLA‐fed SCD1−/− mice.Conclusion: OA may inhibit SCD1 gene expression to ameliorate fructose‐induced hepatosteatosis through SREBP1c‐dependent and ‐independent mechanisms.
- 8 May 2023
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 67 (12) , e2200533
Oleanolic Acid Inhibits SCD1 Gene Expression to Ameliorate Fructose‐Induced Hepatosteatosis through SREBP1c‐Dependent and ‐Independent Mechanisms
Scope: The mechanisms of oleanolic acid (OA) regulating hepatic sterol regulatory element‐binding protein (SREBP) 1c/stearoyl‐CoA desaturase (SCD) 1 pathway to ameliorate fructose‐induced hepatosteatosis are investigated.Methods and results: Rats treated with 10% w/v fructose solution are co‐administered by OA for 5 weeks, and then sacrifice after fasting for 14 h. OA reverses the fructose‐induced increase in hepatic triglyceride (TG) content and downregulates Scd1 mRNA expression. However, two upstream transcription factors, ChREBP and SREBP1c, remain at normal levels with or without fructose and/or OA. In vivo and in vitro studies using SREBP1c−/− mice and HepG2 cell models show that OA also inhibits SCD1 gene overexpression and high hepatic TG levels induced by fructose. On the other hand, in SCD1−/− mice, when the fructose diet is supplemented with high levels of oleic acid (OLA) to compensate for the deficiency of SCD1, OA inhibits hepatic SREBP1c and lipogenic gene expression and reduces hepatic OLA (C18:1) production to improve fructose and/or OLA induced liver lipid deposition. Furthermore, OA promotes PPARα and AMPK to enhance fatty acid oxidation in fructose + OLA‐fed SCD1−/− mice.Conclusion: OA may inhibit SCD1 gene expression to ameliorate fructose‐induced hepatosteatosis through SREBP1c‐dependent and ‐independent mechanisms.
- Open Access
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 9726431
In Vitro and In Vivo Antioxidative Activity against Radiation‐Induced Damage and the Systematic Chemical Components of Different Extracts of Lagotis brevituba Maxim
Lagotis brevituba Maxim is a perennial species distributed in the highlands of China, which has been used for more than 2000 years as a traditional Tibetan medicinal plant. However, no attention has been paid to the antioxidant activities of Lagotis brevituba Maxim in vitro or in vivo. Thus, this study aimed to evaluate the in vitro and in vivo antioxidant activity of Lagotis brevituba Maxim against radiation‐induced damage as well as the systematic chemical components. To explore the relationship between the antioxidant activity and extraction solvent, Lagotis brevituba Maxim was extracted with three different solvents: methanol, water, and acetone. In antioxidant assays in vitro, the water extract had the strongest reducing power, 2,2‐azino‐bis(3‐ethylbenzothiazoline‐6‐sulfonic acid) diammonium salt (ABTS) radical, and 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH) radical scavenging activity compared with the methanol and acetone extracts. However, the methanol extract was more potent in the β‐carotene/linoleic acid cooxidation assay. In antioxidant assays in vivo, mice that were exposed to 6.0 Gy60Co γ‐ray whole‐body radiation on day 15 after administration of Lagotis brevituba Maxim decreased their level of malondialdehyde (MDA) in a dose‐dependent manner compared with the control group, indicating that Lagotis brevituba Maxim had favorable antioxidant activities in vivo. In addition, a total of 44 compounds were tentatively identified by liquid chromatography electrospray ionization quadrupole time‐of‐flight mass spectrometry (LC‐ESI‐QTOF‐MS/MS), including 19 flavonoids, 14 phenols, 8 phenylethanoid glycosides, 2 iridoid glycosides, and 1 carbohydrate. We obtained 25 compounds from plants in the genus Lagotis for the first time. These results suggested that Lagotis brevituba Maxim had potent antioxidant activity and could be explored as a novel natural antioxidant.
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 9726431
Open AccessIn Vitro and In Vivo Antioxidative Activity against Radiation‐Induced Damage and the Systematic Chemical Components of Different Extracts of Lagotis brevituba Maxim
Lagotis brevituba Maxim is a perennial species distributed in the highlands of China, which has been used for more than 2000 years as a traditional Tibetan medicinal plant. However, no attention has been paid to the antioxidant activities of Lagotis brevituba Maxim in vitro or in vivo. Thus, this study aimed to evaluate the in vitro and in vivo antioxidant activity of Lagotis brevituba Maxim against radiation‐induced damage as well as the systematic chemical components. To explore the relationship between the antioxidant activity and extraction solvent, Lagotis brevituba Maxim was extracted with three different solvents: methanol, water, and acetone. In antioxidant assays in vitro, the water extract had the strongest reducing power, 2,2‐azino‐bis(3‐ethylbenzothiazoline‐6‐sulfonic acid) diammonium salt (ABTS) radical, and 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH) radical scavenging activity compared with the methanol and acetone extracts. However, the methanol extract was more potent in the β‐carotene/linoleic acid cooxidation assay. In antioxidant assays in vivo, mice that were exposed to 6.0 Gy60Co γ‐ray whole‐body radiation on day 15 after administration of Lagotis brevituba Maxim decreased their level of malondialdehyde (MDA) in a dose‐dependent manner compared with the control group, indicating that Lagotis brevituba Maxim had favorable antioxidant activities in vivo. In addition, a total of 44 compounds were tentatively identified by liquid chromatography electrospray ionization quadrupole time‐of‐flight mass spectrometry (LC‐ESI‐QTOF‐MS/MS), including 19 flavonoids, 14 phenols, 8 phenylethanoid glycosides, 2 iridoid glycosides, and 1 carbohydrate. We obtained 25 compounds from plants in the genus Lagotis for the first time. These results suggested that Lagotis brevituba Maxim had potent antioxidant activity and could be explored as a novel natural antioxidant.
- 1 December 2016
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 194, 288-298
Jiangzhi Capsule improves fructose-induced insulin resistance in rats: Association with repair of the impaired sarcolemmal glucose transporter-4 recycling
- 1 December 2016
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 194, 288-298
Jiangzhi Capsule improves fructose-induced insulin resistance in rats: Association with repair of the impaired sarcolemmal glucose transporter-4 recycling